V. Cottin, F. Capron, P. Grenier, and J. Cordier, Diffuse idiopathic interstitial pneumonias. International multidisciplinary consensus classification by the

, Rev. Mal. Respir, vol.21, pp.299-318, 2004.

W. D. Travis, U. Costabel, D. M. Hansell, T. E. King, D. A. Lynch et al., An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias, Am J Respir Crit Care Med, vol.188, issue.6, p.48, 2013.

, European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the, Am J Respir Crit Care Med, vol.165, issue.2, pp.277-304, 2001.

J. Hetzel, F. Maldonado, C. Ravaglia, A. U. Wells, T. V. Colby et al.,

, Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure, Respiration, vol.95, issue.3, pp.188-200, 2018.

L. Nalysnyk, J. Cid-ruzafa, P. Rotella, and D. Esser, Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature, Eur Respir Rev Off J Eur Respir Soc, vol.21, issue.126, p.61, 2012.

U. Hodgson, T. Laitinen, and P. Tukiainen, Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland, Thorax, vol.57, issue.4, pp.338-380, 2002.

J. Gribbin, R. B. Hubbard, L. Jeune, I. Smith, C. West et al., Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK, Thorax, vol.61, issue.11, pp.980-985, 2006.

G. Raghu, H. R. Collard, J. J. Egan, F. J. Martinez, J. Behr et al., An official diagnosis and management, Am J Respir Crit Care Med, vol.183, issue.6, pp.788-824, 2011.

H. Lee, J. H. Ryu, M. H. Wittmer, T. E. Hartman, J. F. Lymp et al.,

. Jh, M. H. Wittmer, T. E. Hartman, J. F. Lymp, H. D. Tazelaar et al., Familial idiopathic pulmonary fibrosis: clinical features and outcome, Chest, vol.127, pp.2034-2075, 2005.

C. García-sancho, I. Buendía-roldán, M. R. Fernández-plata, C. Navarro, and R. Pérez-padilla,

M. H. Vargas, Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis, Respir Med, vol.105, issue.12, pp.1902-1909, 2011.

M. P. Steele, M. C. Speer, J. E. Loyd, K. K. Brown, A. Herron et al., Clinical and Pathologic Features of Familial Interstitial Pneumonia, Am J Respir Crit Care Med, vol.172, issue.9, pp.1146-52, 2005.

R. P. Marshall, A. Puddicombe, W. Cookson, and G. J. Laurent, Adult familial cryptogenic fibrosing alveolitis in the United Kingdom, Thorax, vol.55, issue.2, pp.143-149, 2000.

B. A. Fernandez, G. Fox, R. Bhatia, E. Sala, B. Noble et al.,

A. Dohey, F. Kamel, L. Edwards, K. Mahoney, S. Stuckless et al., A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features, Respir Res, vol.13, p.64, 2012.

M. B. Scholand, H. Coon, R. Wolff, and L. Cannon-albright, Use of a genealogical database demonstrates heritability of pulmonary fibrosis, Lung, vol.191, issue.5, p.81, 2013.

J. A. Kropski, T. S. Blackwell, and J. E. Loyd, The genetic basis of idiopathic pulmonary fibrosis

, Eur Respir J, vol.45, issue.6, pp.1717-1744, 2015.

M. Armanios and E. H. Blackburn, The telomere syndromes, Nat Rev Genet, vol.13, issue.10, pp.693-704, 2012.
DOI : 10.1038/nrg3246

URL : http://europepmc.org/articles/pmc3548426?pdf=render

A. J. Walne, T. Vulliamy, M. Kirwan, V. Plagnol, and I. Dokal, Constitutional mutations in RTEL1 cause severe dyskeratosis congenita, Am J Hum Genet, vol.92, issue.3, pp.448-53, 2013.
DOI : 10.1016/j.ajhg.2013.02.001

URL : https://doi.org/10.1016/j.ajhg.2013.02.001

F. Touzot, L. Kermasson, L. Jullien, D. Moshous, C. Ménard et al.,

, Extended clinical and genetic spectrum associated with biallelic RTEL1 mutations, Blood Adv, vol.1, issue.1, pp.36-46, 2016.

M. Armanios, Telomerase and idiopathic pulmonary fibrosis, Mutat Res, vol.730, issue.1, pp.52-60, 2012.

J. D. Cogan, J. A. Kropski, M. Zhao, D. B. Mitchell, L. Rives et al., Rare variants in RTEL1 are associated with familial interstitial pneumonia, Am J Respir Crit Care Med, vol.191, issue.6, pp.646-55, 2015.
DOI : 10.1164/rccm.201408-1510oc

URL : http://europepmc.org/articles/pmc4384777?pdf=render

M. Armanios and E. H. Blackburn, The telomere syndromes, Nat Rev Genet, vol.13, issue.10, pp.693-704, 2012.
DOI : 10.1038/nrg3246

URL : http://europepmc.org/articles/pmc3548426?pdf=render

A. Diaz-de-leon, J. T. Cronkhite, A. Katzenstein, J. D. Godwin, G. Raghu et al.,

, Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations, PloS One, vol.5, issue.5, p.10680, 2010.

J. T. Cronkhite, C. Xing, G. Raghu, K. M. Chin, F. Torres et al., Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis, Am J Respir Crit Care Med, vol.178, issue.7, p.37, 2008.
DOI : 10.1164/rccm.200804-550oc

URL : http://europepmc.org/articles/pmc2556455?pdf=render

J. K. Alder, V. S. Hanumanthu, M. A. Strong, A. E. Dezern, S. E. Stanley et al.,

, Diagnostic utility of telomere length testing in a hospital-based setting, Proc Natl Acad Sci, vol.115, issue.10, pp.2358-65, 2018.

F. Goldman, R. Bouarich, S. Kulkarni, S. Freeman, H. Du et al., The effect of TERC haploinsufficiency on the inheritance of telomere length, Proc Natl Acad Sci U S A, vol.102, issue.47, pp.17119-17143, 2005.

M. Y. Armanios, J. Chen, J. D. Cogan, J. K. Alder, R. G. Ingersoll et al., Telomerase mutations in families with idiopathic pulmonary fibrosis, N Engl J Med, vol.356, issue.13, pp.1317-1343, 2007.
DOI : 10.1056/nejmoa066157

J. K. Alder, J. D. Cogan, A. F. Brown, C. J. Anderson, W. E. Lawson et al., Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis, PLoS Genet, vol.7, issue.3, p.1001352, 2011.
DOI : 10.1371/journal.pgen.1001352

URL : https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1001352&type=printable

N. S. Heiss, S. W. Knight, T. J. Vulliamy, S. M. Klauck, S. Wiemann et al.,

, Nat Genet, vol.19, issue.1, pp.32-40, 1998.

V. Mialou, T. Leblanc, P. De-latour, R. Dalle, J. H. Socié et al., Dyskeratosis congenital: an update, Arch Pediatr, vol.20, issue.3, pp.299-306, 2013.

I. D. Dokal and . Congenita, ASH Educ Program Book, issue.1, pp.480-486, 2011.

K. D. Tsakiri, J. T. Cronkhite, P. J. Kuan, C. Xing, G. Raghu et al., Adult-onset pulmonary fibrosis caused by mutations in telomerase, Proc Natl Acad Sci U S A, vol.104, issue.18, pp.7552-7559, 2007.
DOI : 10.1073/pnas.0701009104

URL : http://europepmc.org/articles/pmc1855917?pdf=render

A. Diaz-de-leon, J. T. Cronkhite, A. Katzenstein, J. D. Godwin, G. Raghu et al.,

, Telomere Lengths, Pulmonary Fibrosis and Telomerase, vol.5, p.10680, 2010.

J. K. Alder, N. Guo, F. Kembou, E. M. Parry, C. J. Anderson et al., Telomere Length Is a Determinant of Emphysema Susceptibility, Am J Respir Crit Care Med, vol.184, issue.8, pp.904-916, 2011.

H. Nunes, I. Monnet, C. Kannengiesser, Y. Uzunhan, D. Valeyre et al., Is Telomeropathy the Explanation for Combined Pulmonary Fibrosis and Emphysema Syndrome?: Report of a Family with TERT Mutation, Am J Respir Crit Care Med, vol.189, issue.6, pp.753-757, 2014.

C. A. Newton, K. Batra, J. Torrealba, J. Kozlitina, C. S. Glazer et al., Telomererelated lung fibrosis is diagnostically heterogeneous but uniformly progressive, Eur Respir J, vol.48, issue.6, p.20, 2016.
DOI : 10.1183/13993003.00308-2016

URL : http://erj.ersjournals.com/content/48/6/1710.full.pdf

R. Borie, L. Tabèze, G. Thabut, H. Nunes, V. Cottin et al., Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis, Eur Respir J, vol.48, issue.6, p.31, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01467555

A. Justet, G. Thabut, E. Manali, M. Molina, M. Kannengiesser et al.,

, Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation, Eur Respir J, vol.51, issue.3, 2018.

P. Barbaro and A. Vedi, Survival after Hematopoietic Stem Cell Transplant in Patients with

D. Congenita, Systematic Review of the Literature, Biol Blood Marrow Transplant, vol.22, issue.7, pp.1152-1158, 2016.

N. Giri, R. Lee, A. Faro, C. B. Huddleston, F. V. White et al., Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review, BMC Blood Disord, vol.11, p.3, 2011.
DOI : 10.1186/1471-2326-11-3

URL : https://bmchematol.biomedcentral.com/track/pdf/10.1186/1471-2326-11-3

A. Diaz-de-leon, J. T. Cronkhite, C. Yilmaz, C. Brewington, R. Wang et al.,

, Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations, Chest, vol.140, issue.3, pp.753-63, 2011.

S. E. Ball, F. M. Gibson, S. Rizzo, J. A. Tooze, J. C. Marsh et al., Progressive telomere shortening in aplastic anemia, Blood, vol.91, issue.10, pp.3582-92, 1998.

H. Yamaguchi, G. M. Baerlocher, P. M. Lansdorp, S. J. Chanock, O. Nunez et al., Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome, Blood, vol.102, issue.3, pp.916-924, 2003.

H. Yamaguchi, R. T. Calado, H. Ly, S. Kajigaya, G. M. Baerlocher et al.,

, J Med, vol.352, issue.14, pp.1413-1437, 2005.

E. M. Parry, J. K. Alder, X. Qi, J. Chen, and M. Armanios, Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase, Blood, vol.117, issue.21, pp.5607-5618, 2011.

D. Hartmann, U. Srivastava, M. Thaler, K. N. Kleinhans, N. 'kontchou et al.,

, Telomerase gene mutations are associated with cirrhosis formation, Hepatol Baltim Md, vol.53, issue.5, pp.1608-1625, 2011.

G. George, I. O. Rosas, Y. Cui, C. Mckane, G. M. Hunninghake et al., Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease, vol.147, pp.1549-57, 2015.
DOI : 10.1378/chest.14-0631

URL : http://europepmc.org/articles/pmc4451709?pdf=render

R. T. Calado, J. A. Regal, D. E. Kleiner, D. S. Schrump, N. R. Peterson et al., A spectrum of severe familial liver disorders associate with telomerase mutations, PloS One, vol.4, issue.11, p.7926, 2009.

R. Borie, C. Kannengiesser, F. S. Fontbrune, . De, D. Boutboul et al., Pneumocystosis revealing immunodeficiency secondary to TERC mutation, Eur Respir J, vol.50, issue.5, p.1701443, 2017.
DOI : 10.1183/13993003.01443-2017

S. W. Knight, N. S. Heiss, T. J. Vulliamy, C. M. Aalfs, C. Mcmahon et al.,

, Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (HoyeraalHreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1, Br J Haematol, vol.07, issue.2, pp.335-344, 1999.

P. Kajtár and K. Méhes, Bilateral coats retinopathy associated with aplastic anaemia and mild dyskeratotic signs, Am J Med Genet, vol.49, issue.4, pp.374-381, 1994.

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med Off J Am Coll Med Genet, vol.17, issue.5, pp.405-429, 2015.

A. Islam, S. Rafiq, M. Kirwan, A. Walne, J. Cavenagh et al., Haematological recovery in dyskeratosis congenita patients treated with danazol, Br J Haematol, vol.162, issue.6, pp.854-860, 2013.
DOI : 10.1111/bjh.12432

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.12432

B. Zlateska, A. Ciccolini, and Y. Dror, Treatment of dyskeratosis congenita-associated 66 pulmonary fibrosis with danazol, Pediatr Pulmonol, vol.50, issue.12, pp.48-51, 2015.

D. M. Townsley, B. Dumitriu, D. Liu, A. Biancotto, B. Weinstein et al., Danazol Treatment for Telomere Diseases, N Engl J Med, vol.374, issue.20, p.31, 2016.
DOI : 10.1056/nejmoa1515319

URL : http://europepmc.org/articles/pmc4968696?pdf=render

L. L. Silhan, P. D. Shah, D. C. Chambers, L. D. Snyder, G. C. Riise et al., Lung transplantation in telomerase mutation carriers with pulmonary fibrosis, Eur Respir J, vol.44, issue.1, pp.178-87, 2014.
DOI : 10.1183/09031936.00060014

URL : http://erj.ersjournals.com/content/44/1/178.full.pdf

T. J. George, G. J. Arnaoutakis, C. A. Beaty, M. R. Pipeling, C. A. Merlo et al., Acute kidney injury increases mortality after lung transplantation, Ann Thorac Surg, vol.94, issue.1, pp.185-92, 2012.
DOI : 10.1016/j.athoracsur.2011.11.032

URL : http://europepmc.org/articles/pmc3601658?pdf=render

R. Borie, C. Kannengiesser, S. Hirschi, L. Pavec, J. Mal et al., Severe hematologic complications after lung transplantation in patients with telomerase complex mutations, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.34, issue.4, pp.538-584, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01146848

S. Tokman, J. P. Singer, M. S. Devine, G. P. Westall, A. Tamm et al., Clinical outcomes of lung transplant recipients with telomerase mutations, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.34, issue.10, pp.1318-1342, 2015.

M. Lebeer, W. A. Wuyts, D. Cassiman, W. Laleman, F. Nevens et al., Multiple Solid, Organ Transplantation In Telomeropathy: Case Series And Literature Review. Transplantation, 2018.

S. Stewart, M. C. Fishbein, G. I. Snell, G. J. Berry, A. Boehler et al., Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.26, issue.12, p.42, 2007.

K. C. Meyer, G. Raghu, G. M. Verleden, P. A. Corris, A. P. Wilson et al., An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome, Eur Respir J, vol.44, issue.6, pp.1479-503, 2014.

F. Robert-gangneux, S. Belaz, M. Revest, P. Tattevin, S. Jouneau et al.,

L. Tulzo, Y. Gangneux, and J. P. , Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study, J Clin Microbiol, vol.52, issue.9, pp.3370-3376, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01063906

H. Nunes, F. Jeny, D. Bouvry, C. Picard, J. F. Bernaudin et al.,

C. Kannengiesser, D. Valeyre, and M. Kambouchner, Pleuroparenchymal fibroelastosis associated with telomerase reverse transcriptase mutations, Eur Respir J, vol.49, issue.5, 2017.

C. A. Newton, K. Batra, J. Torrealba, K. Meyer, G. Raghu et al., Pleuroparenchymal Fibroelastosis Associated with TERT Mutations, Eur Respir J, vol.49, issue.5, 2017.

C. Maslo, M. N. Peraldi, J. C. Desenclos, B. Mougenot, C. Cywiner-golenzer et al., Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.24, issue.3, pp.350-355, 1997.

K. Ramasubbu, T. Mullick, K. A. Hussein, M. Henderson, J. M. Mullen et al.,

, Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a casebased review, Transpl Infect Dis Off J Transplant Soc, vol.5, issue.2, p.103, 2003.

F. M. Jeejeebhoy and J. S. Zaltzman, Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment stratey

, Transplantation, vol.65, issue.12, pp.1645-1653, 1998.

H. Mal, A. Veyradier, O. Brugière, D. Silva, D. Colombat et al., Thrombotic microangiopathy with acquired deficiency in ADAMTS 13 activity in lung transplant recipients, Transplantation, vol.81, issue.12, p.32, 2006.

L. Savale, L. Pavec, J. Mercier, O. Mussot, S. Jaïs et al., Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension, Ann Thorac Surg, vol.104, issue.2, p.11, 2017.

A. Roux, L. Beaumont-azuar, A. M. Hamid, D. Miranda, S. Grenet et al., High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortality, Transpl Int Off J Eur Soc Organ Transplant, vol.28, issue.9, pp.1092-101, 2015.

J. D. Christie, L. B. Edwards, A. Y. Kucheryavaya, C. Benden, F. Dobbels et al., Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth

, Adult Lung and Heart-Lung Transplant Report--2011, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.30, issue.10, pp.1104-1126, 2011.

D. Chauhan, A. B. Karanam, A. Merlo, T. Bozzay, P. A. Zucker et al.,

, Post-transplant survival in idiopathic pulmonary fibrosis patients concurrently listed for single and double lung transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.35, issue.5, p.60, 2016.

A. Glatard, S. Hillaire, G. Assignies, D. Cazals-hatem, A. Plessier et al.,

, Obliterative portal venopathy: findings at CT imaging, Radiology, vol.263, issue.3, p.68, 2012.

M. Paradela-de-la-morena, D. La-torre-bravos, M. Prado, R. F. Roel, M. D. Salcedo et al.,

E. F. Costa, Chronic kidney disease after lung transplantation: incidence, risk factors, and treatment, Transplant Proc, vol.42, issue.8, pp.3217-3226, 2010.

A. Solé, F. Zurbano, J. M. Borro, V. Monforte, P. Ussetti et al., Prevalence and Diagnosis of Chronic Kidney Disease in Maintenance Lung Transplant Patients: ICEBERG Study, Transplant Proc, vol.47, issue.6, p.71, 1966.

D. P. Mason, M. Solovera-rozas, J. Feng, J. Rajeswaran, L. Thuita et al., Dialysis after lung transplantation: prevalence, risk factors and outcome, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.26, issue.11, pp.1155-62, 2007.
DOI : 10.1016/j.healun.2007.08.006

C. Kubal, P. Cockwell, B. Gunson, M. Jesky, R. Hanvesakul et al., Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring, Transplantation, vol.93, issue.4, pp.406-417, 2012.

S. Lata, M. Marasa, Y. Li, D. A. Fasel, E. Groopman et al., Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study, Ann Intern Med, vol.168, issue.2, pp.100-109, 2018.

R. D. Yusen, L. B. Edwards, A. Y. Kucheryavaya, C. Benden, A. I. Dipchand et al., The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.33, issue.10, pp.1009-1033, 2014.

K. C. Meyer, G. Raghu, G. M. Verleden, P. A. Corris, A. P. Wilson et al., An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome, Eur Respir J, vol.44, issue.6, pp.1479-503, 2014.

C. A. Newton, J. Kozlitina, J. R. Lines, V. Kaza, F. Torres et al., Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and postlung transplantation survival, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.36, issue.8, pp.845-53, 2017.